Browse All
Displaying 6 - 8 of 8
Author:Bar-Or, Amit Wiendl, Heinz De Seze, Jerome Correale, Jorge Cross, Anne Derfuss, Tobias Selmaj, Krzysztof Winthrop, Kevin Giacomini, Paul Sacca, Francesco Hu, Xixi Sullivan, Roseanne Jehl, Valentine Boer, Ibolya Bhatt, Alit Hauser, Stephen
Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2
Topic:Multiple Sclerosis
Program Number:P9.007
Author Institution:Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA University of Muenster, Muenster, Germany University Hospital of Strasbourg, Strasbourg, France Institute for Neurological Research Dr. Raul Carrea, Buenos Aires, Argentina Washington University School of Medicine, Clayton, MO Neurology Clinic and Policlinic and Research Center for Clinical Neuroimmunology and Neuroscience, Departments of Medicine and Biomedicine, University Hospital and University of Basel, Basel, Switzerland Center for Neurology, Lodz, Lodz, Poland Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health and Sciences University, Portland, OR Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada NSRO Department, University “Federico II” of Naples, Naples, Italy Novartis Pharmaceuticals Corporation, East Hanover, NJ Novartis Pharma AG, Basel, Switzerland Novartis Healthcare Pvt. Ltd., Hyderabad, India UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA
Author:Wiendl, Heinz Hauser, Stephen Nicholas, Jacqueline De Seze, Jerome Meuth, Sven Giacomini, Paul Robertson, Derrick Wray, Sibyl Bhatt, Alit Hu, Xixi Fu, Haoyi Jehl, Valentine Sullivan, Roseanne Boer, Ibolya Cohen, Jeffrey Kappos, Ludwig
Program Number:P9.010
Author Institution:University of Münster, Münster, Germany, Muenster, Germany UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, United States, San Francisco, CA OhioHealth Multiple Sclerosis Center, Columbus, OH, USA, Columbus, OH University Hospital of Strasbourg, Strasbourg, France, Strasbourg, France Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany, Duesseldorf, Germany Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada, Montreal, QC, Canada Multiple Sclerosis Division, Department of Neurology, University of South Florida, Tampa, FL, USA, Tampa, FL Hope Neurology MS Center, Knoxville, TN, USA, Knoxville, TN Novartis Healthcare Pvt. Ltd., Hyderabad, India, Hyderabad, India Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, Morristown, NJ Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, East Hanover, NJ Novartis Pharma A.G. Basel, Switzerland, Basel, Switzerland Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, Departments of Headorgans, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland
Author:Levy, Michael Sotirchos, Elias Carment, Loic Gorin, Clarissa Klaeyle, Lissandra Ravindra, Dellini Touré Cuq, Emma Vivès, Alizé Fam, Sami Kielhorn, Adrian Aras, Emrah Zinaï, Saad De Seze, Jerome
Session Name:P10: Autoimmune Neurology: NMOSD
Topic:Autoimmune Neurology
Program Number:P10.001
Author Institution:Massachusetts General Hospital/Harvard Medical School, Boston, USA, Boston, MA Johns Hopkins University, Baltimore, USA, Baltimore, MD Ad Scientiam, Paris, France, Paris, France Alexion, AstraZeneca Rare Disease, Boston, MA, Wayland, MA Hôpital Civil, Strasbourg University, Strasbourg, France, Strasbourg, France
